Cited by 205Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsEndometriosis Research and Treatment

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes

Open access

Guastella, Ettore, Longo, Rosa Alba, Carmina, Enrico·2010·Fertility and Sterility

DOI 10.1016/j.fertnstert.2010.02.014

Open this paper in CoChat — free account

Abstract

Objective To evaluate the clinical and endocrine differences between main polycystic ovary syndrome (PCOS) phenotypes.Design To evaluate clinical and hormone parameters in a large group of consecutive women with PCOS diagnosed according Rotterdam criteria and divided according their phenotype.Setting University department of medicine.Patient(s) Three hundred eighty-two consecutive women with PCOS and 85 ovulatory controls.Intervention(s) Evaluation of clinical and hormone parameters.Main outcome measure(s) Blood levels of gonadotropins, testosterone, sex-hormone-binding globulin, dehydroepiandrosterone sulfate, 17α-hydroxyprogesterone, progesterone, glucose, and insulin, and calculation of the free androgen index and insulin sensitivity.Result(s) The severe PCOS phenotype (hyperandrogenism, chronic anovulation, and polycystic ovaries: type I classic PCOS) was the most common phenotype in 53.9% of the patients. The phenotype of 8.9% of patients was characterized by hyperandrogenism and chronic anovulation but normal ovaries (type II classic PCOS). The two phenotypes of classic PCOS had similar clinical and endocrine characteristics, but the patients with polycystic ovaries had a higher luteinizing hormone/follicle-stimulating hormone (LH/FSH) ratio. Ovulatory PCOS was relatively common (28.8% of PCOS patients) and presented milder clinical and endocrine alterations than the classic PCOS phenotypes. The normoandrogenic phenotype was relatively uncommon. These patients had a normal body mass index, insulin sensitivity, and free androgen index but showed increased levels of LH and LH/FSH ratio.Conclusion(s) Ovulatory PCOS represents the mild form of classic PCOS, but the normoandrogenic phenotype, although part of the spectrum, may represent a different disorder or have a different pathogenetic pathway.

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2010.02.014

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Men at risk: occupation and male infertility.
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,219
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Self-citation
Ultrasound assessment of the polycystic ovary: international consensus definitions
Balen, A. H., Laven, J. S. E., Tan, S.-L., & Dewailly, D. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg044 · Cited by 1,015
Hirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. R. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,013
Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex
Ludwig, E. (1977) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1977.tb15179.x · Cited by 881
Evaluation of assays available to measure free testosterone
Morley, J. E., Patrick, P., & Perry, H. M. (2002) · Metabolism · doi:10.1053/meta.2002.31975 · Cited by 309
Polycystic Ovary Syndrome
Dunaif, A., Heindel, J. J., & Chang, R. (2002) · CRC Press eBooks · doi:10.3109/9780203910948 · Cited by 283
Restoration of Reproductive Potential by Lifestyle Modification in Obese Polycystic Ovary Syndrome: Role of Insulin Sensitivity and Luteinizing Hormone
Huber-Buchholz, M.-M. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.4.1470 · Cited by 269

Flagged first, then by citations

Show all 23 references

Sorted by citations

The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Polycystic ovary syndrome
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citation
The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
Dewailly, D., Lujan, M. E., Carmina, E., Cedars, M. I., Laven, J., Norman, R. J., & Escobar-Morreale, H. F. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt061 · Cited by 551
Self-citation
Genetic Basis of Polycystic Ovary Syndrome (PCOS): Current Perspectives
Khan, M. J., Ullah, A., & Basit, S. (2019) · The Application of Clinical Genetics · doi:10.2147/tacg.s200341 · Cited by 412
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262
Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis
Zhao, Y., Fu, L., Li, R., Wang, L., Yan, Y., Liu, N.-N., Zhang, C., Wang, Y., Liu, P., Tu, B.-B., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-153 · Cited by 232
Polycystic Ovary Syndrome
Meier, R. K. (2018) · Nursing Clinics of North America · doi:10.1016/j.cnur.2018.04.008 · Cited by 208
Polycystic ovary syndrome as a metabolic disease
Helvacı, N., & Yıldız, B. O. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01057-w · Cited by 230
Referral Bias in Defining the Phenotype and Prevalence of Obesity in Polycystic Ovary Syndrome
Ezeh, U., Yildiz, B. O., & Azziz, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1295 · Cited by 193
Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis
Lizneva, D., Kirubakaran, R., Mykhalchenko, K., Suturina, L., Chernukha, G., Diamond, M. P., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.07.1121 · Cited by 171
Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study
Panidis, D., Tziomalos, K., Misichronis, G., Papadakis, E., Betsas, G., Katsikis, I., & Macut, D. (2012) · Human Reproduction · doi:10.1093/humrep/der418 · Cited by 155
Adolescent Anovulation: Maturational Mechanisms and Implications
Rosenfield, R. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1770 · Cited by 139
Criteria, phenotypes and prevalence of polycystic ovary syndrome
Belenkaia, L. V., Лазарева, Л. М., Walker, W., Lizneva, D., & Сутурина, Л. В. (2019) · Minerva Obstetrics and Gynecology · doi:10.23736/s0026-4784.19.04404-6 · Cited by 133
A 20-Year Follow-up of Young Women With Polycystic Ovary Syndrome
Carmina, E., Campagna, A. M., & Lobo, R. A. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31823f7135 · Cited by 128
Self-citation
Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome
Li, Y., Zheng, Q., Sun, D., Cui, X., Chen, S., Ahmmed, B., Liu, S., & Yan, Q. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27501 · Cited by 112
Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome
Clark, N. M., Podolski, A. J., Brooks, E. D., Chizen, D. R., Pierson, R. A., Lehotay, D. C., & Lujan, M. E. (2014) · Reproductive Sciences · doi:10.1177/1933719114522525 · Cited by 103
Female infertility of endocrine origin
Weiss, R. V., & Clapauch, R. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003021 · Cited by 104
Polycystic ovary syndrome phenotypes and prevalence: Differential impact of diagnostic criteria and clinical versus unselected population
Mümüşoğlu, S., & Yıldız, B. O. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.03.004 · Cited by 107
Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
Iervolino, M., Lepore, E., Forte, G., Laganà, A. S., Buzzaccarini, G., & Unfer, V. (2021) · Nutrients · doi:10.3390/nu13051677 · Cited by 98
Polycystic Ovary Syndrome May Be an Autoimmune Disorder
Mobeen, H., Afzal, N., & Kashif, M. (2016) · Scientifica · doi:10.1155/2016/4071735 · Cited by 95
Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis
Tehrani, F. R., Amiri, M., Behboudi‐Gandevani, S., Yarandi, R. B., & Carmina, E. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1650337 · Cited by 97
Self-citation
Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
Moran, C., Arriaga, M., Rodriguez, G., & Moran, S. (2012) · International Journal of Endocrinology · doi:10.1155/2012/317241 · Cited by 86
Serum anti-mullerian hormone levels in the main phenotypes of polycystic ovary syndrome
Şahmay, S., Atakul, N., Öncül, M., Tüten, A., Mathyk, B. A., & Seyisoğlu, H. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.05.019 · Cited by 83
A case–control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria
Jamil, A. S., Alalaf, S., Al-Tawil, N. G., & Al‐Shawaf, T. (2015) · Reproductive Health · doi:10.1186/1742-4755-12-7 · Cited by 86
Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
Al‐Jefout, M., Alnawaiseh, N. A., & Al-Qtaitat, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-05717-y · Cited by 83
Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the rotterdam criteria
Jamil, A. S., Alalaf, S. K., Al-Tawil, N. G., & Al-Shawaf, T. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3889-5 · Cited by 73
The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum
Rosenfield, R. L. (2014) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2014.07.016 · Cited by 76
Prevalence of polycystic ovary syndrome in European countries and USA: A systematic review and meta-analysis
Chiaffarino, F., Cipriani, S., Dalmartello, M., Ricci, E. D., Esposito, G., Fedele, F., Vecchia, C. L., Negri, E., & Parazzini, F. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.10.020 · Cited by 75
A 20-Year Follow-up of Young Women With Polycystic Ovary Syndrome
Dungan, J. S. (2012) · Yearbook of Obstetrics Gynecology and Women s Health · doi:10.1016/j.yobg.2012.06.193 · Cited by 72
Comparing Lean and Obese PCOS in Different PCOS Phenotypes: Evidence That the Body Weight Is More Important than the Rotterdam Phenotype in Influencing the Metabolic Status
Carmina, E., & Løbo, R. A. (2022) · Diagnostics · doi:10.3390/diagnostics12102313 · Cited by 74
Self-citation
Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach
Nautiyal, H., Imam, S. S., Alshehri, S., Ghoneim, M. M., Afzal, M., Alzarea, S. I., Güven, E., Al-Abbasi, F. A., & Kazmi, I. A. (2022) · Biomedicines · doi:10.3390/biomedicines10030540 · Cited by 80
Adrenal Androgen Excess and Body Mass Index in Polycystic Ovary Syndrome
Morán, C., Arriaga, M., Arechavaleta-Velasco, F., & Morán, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2569 · Cited by 67
Puberty and its disorders in the female
Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00024-x · Cited by 67
MicroRNAs related to androgen metabolism and polycystic ovary syndrome
Sørensen, A. E., Udesen, P. B., Wissing, M. L., Englund, A. L. M., & Dalgaard, L. T. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.008 · Cited by 65
Acne in the adult female patient: a practical approach
Kamangar, F., & Shinkai, K. (2012) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2012.05519.x · Cited by 62
Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter?
Domenico, K. D., Wiltgen, D., Nickel, F. J., Magalhães, J. A. D. A., Moraes, R. S., & Spritzer, P. M. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.049 · Cited by 61
The 312 N variant of the luteinizing hormone/choriogonadotropin receptor gene ( LHCGR ) confers up to 2·7‐fold increased risk of polycystic ovary syndrome in a S ardinian population
Capalbo, A., Sagnella, F., Apa, R., Fulghesu, A. M., Lanzone, A., Morciano, A., Farcomeni, A., Gangalè, M. F., Moro, F., Martínez, D., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04372.x · Cited by 58
Amh Measurement Versus Ovarian Ultrasound In The Diagnosis Of Polycystic Ovary Syndrome In Different Phenotypes
Carmina, E., Campagna, A. M., Fruzzetti, F., & Løbo, R. A. (2015) · Endocrine Practice · doi:10.4158/ep15903.or · Cited by 57
Self-citation
Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome
Krentowska, A., & Kowalska, I. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3464 · Cited by 56
Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors
Carmina, E., Campagna, A. M., & Lobo, R. A. (2013) · Human Reproduction · doi:10.1093/humrep/det119 · Cited by 56
Self-citation
Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome
Christ, J. P., Willis, A. D., Brooks, E. D., Brink, H. V., Jarrett, B. Y., Pierson, R. A., Chizen, D. R., & Lujan, M. E. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.001 · Cited by 54
A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome
Du, Q., Wang, Y.-J., Yang, S., Wu, B., Han, P., & Zhao, Y.-Y. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.681636 · Cited by 53
Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome
Lambrinoudaki, I. V. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.09.005 · Cited by 51
Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS)
Shirazi, F. K. H., Khodamoradi, Z., & Jeddi, M. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00710-z · Cited by 58
Androgens and Hypertension in Men and Women: a Unifying View
Moretti, C., Lanzolla, G., Moretti, M., Gnessi, L., & Carmina, E. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0740-3 · Cited by 49
Self-citation
Endometrium in women with polycystic ovary syndrome during the window of implantation
Lopes, I. M. R. S., Baracat, M. C. P., JesusSimões, M., Simões, R. S., Baracat, E. C., & Soares, J. M. (2011) · Revista da Associação Médica Brasileira (English Edition) · doi:10.1016/s2255-4823(11)70138-2 · Cited by 49
Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes
Cela, V., Obino, M. E. R., Alberga, Y., Pinelli, S., Sergiampietri, C., Casarosa, E., Simi, G., Papini, F., & Artini, P. G. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1412429 · Cited by 47
Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome
Choi, Y. S., Yang, H. I., Cho, S., Jung, J. A., Jeon, Y. E., Kim, H. Y., Seo, S. K., & Lee, B. S. (2012) · Steroids · doi:10.1016/j.steroids.2012.08.005 · Cited by 46
Evolutionary origins of polycystic ovary syndrome: An environmental mismatch disorder
Charifson, M. A., & Trumble, B. C. (2019) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoz011 · Cited by 44
Do the Interactions between Glucocorticoids and Sex Hormones Regulate the Development of the Metabolic Syndrome?
Alemany, M. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00027 · Cited by 45
Endométrio na janela de implantação em mulheres com síndrome dos ovários policísticos
Lopes, J. M., Baracat, M. C. P., Simões, M. D. J., Simões, R. S., Baracat, E. C., & Soares, J. M. (2011) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302011000600020 · Cited by 42
Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: A prospective controlled study
Dalamaga, Μ., Papadavid, E., Basios, G., Vaggopoulos, V., Rigopoulos, D., Kassanos, D., & Trakakis, E. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.09.014 · Cited by 42
Assessment of gut microbial β-glucuronidase and β-glucosidase activity in women with polycystic ovary syndrome
Patel, J. K., Chaudhary, H., Rajput, K. N., Parekh, B., & Joshi, R. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-39168-5 · Cited by 39
Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes
Dilbaz, B., Özkaya, E., Çınar, M., Çakır, E., & Dilbaz, S. (2011) · Endocrine · doi:10.1007/s12020-011-9437-6 · Cited by 39
Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies
Mendoza, N., Simoncini, T., & Genazzani, A. D. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.943725 · Cited by 38
Polycystic ovary syndrome (PCOS) and oxidative stress
Sengupta, P., Dutta, S., & Hassan, M. F. (2024) · Journal of Integrated Science and Technology · doi:10.62110/sciencein.jist.2024.v12.752 · Cited by 37
Cardiovascular and metabolic risks associated with PCOS
Cobin, R. H. (2013) · Internal and Emergency Medicine · doi:10.1007/s11739-013-0924-z · Cited by 35
Higher Metabolic Risk with National Institutes of Health Versus Rotterdam Diagnostic Criteria for Polycystic Ovarian Syndrome in Turkish Women
Anaforoğlu, İ., Algün, E., İnceçayır, Ö., & Ersoy, K. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0019 · Cited by 35
Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily
Carmina, E., Nasrallah, M., Guastella, E., & Løbo, R. A. (2019) · Clinical Endocrinology · doi:10.1111/cen.14063 · Cited by 34
Self-citation
Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women
Dadachanji, R., Patil, A. D., Joshi, B. N., & Mukherjee, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246862 · Cited by 34
Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome
Falcetta, P., Benelli, E., Molinaro, A., Cosmo, C. D., Bagattini, B., Ghianda, S. D., Salvetti, G., Fiore, E., Pucci, E., Fruzzetti, F., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01594-5 · Cited by 36
Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome
Olaniyi, K. S., & Areloegbe, S. E. J. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120560 · Cited by 34
Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?
Carmina, E., & Lobo, R. A. (2018) · Journal of Women s Health · doi:10.1089/jwh.2018.7162 · Cited by 34
Self-citation
Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome
Cankaya, S., Demir, B., Aksakal, S. E., Dilbaz, B., Demirtas, C., & Göktolga, Ü. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.05.032 · Cited by 33
Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study
Pittenger, S. R., Kao, C., Pasch, L. A., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2017) · Fertility Research and Practice · doi:10.1186/s40738-017-0035-z · Cited by 33
Endometrium in women with polycystic ovary syndrome during the window of implantation
Lopes, I. M. R. S., Baracat, M. C. P., JesusSimões, M., Simões, R. S., Baracat, E. C., & Soares, J. M. (2011) · Revista da Associação Médica Brasileira · doi:10.1016/s0104-4230(11)70138-5 · Cited by 33
The Clinical Manifestations of Polycystic Ovary Syndrome (PCOS) and The Treatment Options
Karkera, S., Agard, E., & Sankova, L. (2023) · European Journal of Biology and Medical Science Research · doi:10.37745/ejbmsr.2013/vol11n15791 · Cited by 35
Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study
Bahadori, F., Sadatmahalleh, S. J., & Mirzaei, N. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00811-2 · Cited by 36
Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome
Huang, R., Zheng, J., Li, S., Tao, T., Ma, J., & Liu, W. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12612 · Cited by 30
Influence of Phenotypes on the Metabolic Syndrome of Women with Polycystic Ovary Syndrome over a Six-Year Follow-Up in Brazil
Soares, J. M., Hayashida, S. A. Y., Marcondes, J. A. M., Maciel, G. A. R., Barcellos, C. R. G., Maffazioli, G. D. N., Monteiro, K. K. A. C., Turri, J. A. O., Azziz, R., & Baracat, E. C. (2023) · Biomedicines · doi:10.3390/biomedicines11123262 · Cited by 29
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes
Romualdi, D., Florio, C. D., Tagliaferri, V., Cicco, S. D., Gagliano, D., Immediata, V., Lanzone, A., & Guido, M. (2015) · Reproductive Sciences · doi:10.1177/1933719115611751 · Cited by 29
The PCOS Patients differ in Lipid Profile According to their Phenotypes
Spałkowska, M., Mrozińska, S., Gałuszka-Bednarczyk, A., Gosztyła, K., Przywara, A., Guzik, J., Janeczko, M., Milewicz, T., & Wojas‐Pelc, A. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-121264 · Cited by 28
Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics
Ateş, S., Şevket, O., Sudolmuş, S., Dane, B., Özkal, F., Uysal, Ö., & Dansuk, R. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.819082 · Cited by 28
Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea
Carmina, E., Fruzzetti, F., & Lobo, R. A. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.12.055 · Cited by 27
Self-citation
Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome
Berbrier, D. E., Leone, C. A., Adler, T. E., Bender, J. R., Taylor, H. S., Stachenfeld, N. S., & Usselman, C. W. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00583.2022 · Cited by 27
Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes
Tripathy, P., Sahu, A., Sahu, M., & Nagy, A. C. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.02.031 · Cited by 27
A model of ovulatory regulation examining the effects of insulin-mediated testosterone production on ovulatory function
Graham, E. J., & Selgrade, J. F. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.01.007 · Cited by 25
Health related quality of life among different PCOS phenotypes of infertile women
Dilbaz, B., Çınar, M., Özkaya, E., Tonyalı, N. V., & Dilbaz, S. (2012) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2012.39 · Cited by 24
The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome
Panidis, D., Τζιόμαλος, Κ., Papadakis, E. P., Chatzis, P., Kandaraki, E., Tsourdi, E. A., Vosnakis, C., & Katsikis, I. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0039 · Cited by 24
MicroRNA Expression is Altered in Granulosa Cells of Ovarian Hyperresponders
Xie, S., Batnasan, E., Zhang, Q., & Li, Y. (2016) · Reproductive Sciences · doi:10.1177/1933719115625849 · Cited by 24
RETRACTED: Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function
Carmina, E., Fruzzetti, F., & Lobo, R. A. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1395842 · Cited by 24
Self-citation
Retracted
Transitory Activation of the Central and Ovarian Norepinephrine Systems During Cold Stress‐Induced Polycystic Ovary in Rats
Bernuci, M. P., Leite, C. M., Barros, P. T., Kalil, B., Leoni, G. B., Borges, B. D. B., Franci, C. R., Szawka, R. E., Lara, H. E., & Anselmo-Franci, J. A. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02373.x · Cited by 22
Associations of Estrogen and Testosterone with Insulin Resistance in Pre- and Postmenopausal Women and Postmenopausal Women with Hormone Therapy
Matsui, S., Yasui, T., Tani, A., Kunimi, K., Uemura, H., Yamamoto, S., Kuwahara, A., Matsuzaki, T., & Irahara, M. (2013) · Intern J Endocrinol Metab · doi:10.5812/ijem.5333 · Cited by 22
Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population
Johnstone, E. B., Davis, G., Zane, L. T., Cedars, M. I., & Huddleston, H. G. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.671389 · Cited by 21
Polycystic Ovary Syndrome: Special Diagnostic and Therapeutic Considerations for Children
Kamangar, F., Okhovat, J., Schmidt, T. H., Beshay, A. P., Pasch, L. A., Cedars, M. I., Huddleston, H. G., & Shinkai, K. (2015) · Pediatric Dermatology · doi:10.1111/pde.12566 · Cited by 21
Metabolic profile of women with PCOS in Brazil: a systematic review and meta-analysis
Spritzer, P. M., Ramos, R. B., Marchesan, L. B., de Oliveira, M., & Carmina, E. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00636-5 · Cited by 20
Self-citation
Increased pro-inflammatory cytokines in ovary and effect of γ-linolenic acid on adipose tissue inflammation in a polycystic ovary syndrome model
Prabhu, Y. D., Borthakur, A., Subeka, A. G., Vellingiri, B., & Gopalakrishnan, A. V. (2021) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2021.103345 · Cited by 19
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology
Moghetti, P., Carmina, E., Leo, V. D., Lanzone, A., Orio, F., Pasquali, R., & Toscano, V. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0274-y · Cited by 19
Self-citation
Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome
Ashrafi, M., Sheikhan, F., Arabipoor, A., Rouhana, N. A., Hosseini, R., & Zolfaghari, Z. (2017) · Oman Medical Journal · doi:10.5001/omj.2017.40 · Cited by 18
Correlation between the Serum Luteinizing Hormone to Folliclestimulating Hormone Ratio and the Anti-Müllerian Hormone Levels in Normo-ovulatory Women
Lee, J. E., Yoon, S. H., Kim, H. O., & Min, E. G. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.3.296 · Cited by 17
Dificuldades e armadilhas no diagnóstico da síndrome dos ovários policísticos
Marcondes, J. A. M., Barcellos, C. R. G., & Rocha, M. P. (2011) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302011000100002 · Cited by 17
Hyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
Rosenfield, R. L., Barnes, R. B., & Ehrmann, D. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00133-5 · Cited by 17
Need to Introduce the Finding of Obesity or Normal Body Weight in the Current Diagnostic Criteria and in the Classification of PCOS
Carmina, E. (2022) · Diagnostics · doi:10.3390/diagnostics12102555 · Cited by 16
Self-citation
Reproductive System Outcome Among Patients with Polycystic Ovarian Syndrome
Carmina, E. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.07.006 · Cited by 16
Self-citation
Western-style diet, with and without chronic androgen treatment, alters the number, structure, and function of small antral follicles in ovaries of young adult monkeys
Bishop, C. V., Xu, F., Xu, J., Ting, A. Y., Galbreath, E., McGee, W. K., Zelinski, M. B., Hennebold, J. D., Cameron, J. L., & Stouffer, R. L. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.11.045 · Cited by 16
Connecting Bisphenol A Exposure to PCOS: Findings from a Case-Control Investigation
Patel, J. K., Chaudhary, H., Panchal, S., Parekh, B., & Joshi, R. G. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01548-1 · Cited by 15
A cross-sectional comparison of clinical and endocrine parameters among phenotypes of polycystic ovarian syndrome in iranian population
Amini, P., Samani, R. O., Hosseini, R., Ahmadi, J., & Maroufizadeh, S. (2018) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2018.07.005 · Cited by 15

Authors: Guastella, E., Longo, R. A., & Carmina, E.
Affiliations: University of Palermo (IT)
Corresponding author: Carmina, Enrico
ORCID: Carmina, Enrico
Venue: Fertility and Sterility
Publisher: Elsevier BV
Published: 2010-11
Volume: 94
Issue: 6
Pages: 2197-2201
ISSN: 0015-0282 (ISSN-L)
DOI: 10.1016/j.fertnstert.2010.02.014
OpenAlex: W2129451889
Cited by: 205
References: 23
Citations by year: 2026: 10 · 2025: 12 · 2024: 14 · 2023: 13 · 2022: 15 · 2021: 22 · 2020: 6 · 2019: 5 · 2018: 9 · 2017: 11 · 2016: 16 · 2015: 15 · 2014: 9 · 2013: 16 · 2012: 19
FWCI: 17.91
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4225 d)
Locations: Fertility and Sterility (publishedVersion)
PubMed (publishedVersion)
Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords: polycystic ovary syndrome, PCOS phenotypes, hyperandrogenism, chronic anovulation, LH/FSH ratio, insulin sensitivity, free androgen index, sex hormone-binding globulin, dehydroepiandrosterone sulfate, insulin resistance, Rotterdam criteria
MeSH terms: Adult, Androgens, Endocrine System, Female, Follicle Stimulating Hormone, Humans, Luteinizing Hormone, Phenotype, Polycystic Ovary Syndrome, Retrospective Studies, Sex Hormone-Binding Globulin, Prevalence, Case-Control Studies, Hyperandrogenism, Dehydroepiandrosterone Sulfate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks